[#item_full_content] Aurora Cannabis rejects Curaleaf’s hostile $4/share bid as undervaluing its cash and EU-GMP assets. Read more here.
Read More
[#item_full_content] Aurora Cannabis rejects Curaleaf’s hostile $4/share bid as undervaluing its cash and EU-GMP assets. Read more here.
Read More